By 2012, EULAR will have strengthened activities in areas that are currently less prioritized, such as non-inflammatory and orphan diseases. Within orphan disease scleroderma got the highest vote.
Decision on EULAR Congress 11TH – 14TH June 2008 Paris
Excellent News for Orphan Diseases:
EULAR (European League Against Rheumatism) have developed a strategy for the next 5 years 2008 - 2012 and have 8 Objectives. Objective 1 is that by 2012, EULAR will have strengthened activites in areas that are currently less prioritised, such as non-inflamatory and orphan diseases.Even better news for scleroderma is that EULAR have chosen scleroderma as the orphan disease to concentrate on for the next 5 years and are developing research programmes.
Please read more on EULAR Eigth strategic objectives on www.eular.org